Study of therapeutic effects of infliximab on bone in patients with ankylosing spondylitis using ultrasonography
Qin XUE,Niansong WANG,Yan WU,Jia ZHU,Dongsheng CHENG
DOI: https://doi.org/10.3969/j.issn.1006-7108.2015.02.019
2015-01-01
Abstract:Objective To observe the bone change before and after infliximab treatment in patients with ankylosing spondylitis ( AS) using ultrasonography, and to explore its clinical significance.Methods All the 48 cases of active AS patients met the modified New York criteria (1984), signed informed consent forms, and received 6 times of intravenous infusion of infliximab 5 mg/kg.Bone change on lower limb joints and tendon insertion sites in terms of morphology and blood flow after infliximab treatment was observed using high-resolution B ultrasonography and energy Doppler ultrasonography.Back pain VAS scores, joint swelling and pain, CRP, ESR, BASDAI, DASFI, and BASMI were recorded on week 0 and week 30, respectively.Results Forty-eight cases of AS patients completed the trial, and 31 of them had recheck using ultrasonography.Before the treatment, 37 sites of bone erosion, 2 sites of osteophyte, 17 sites of tendon thickening, 15 sites of bursitis, 1 site of tendon calcification, 22 sites of abnormal blood flow, 11 sites of joint effusion, and 1 site of synovial proliferation were found among the 48 cases using ultrasonography.Thirty weeks after infliximab treatment, 8 sites of bone erosion and 1 site of abnormal blood flow were found among the 31 patients who underwent recheck using ultrasonography.The difference was statistically significant ( P <0.01 ) compared to the amount before the treatment.Three sites of bursitis were found after the treatment, which was statistically different (P<0.05) compared to the amount before the treatment.There were 13 sites of bone erosion found in the tendons of greater trochanter of the femur and 7 sites in the medial collateral ligaments of knee joints before the treatment.However, only 2 sites in the tendons of greater trochanter of the femur and 2 sites in the medial collateral ligaments of knee joints remained after the treatment, and the difference was significant ( P<0.05 ) .Two sites of osteophyte remained after the treatment ( P>0.05 ) .All the clinical indicators improved after the treatment, and the difference was statistically significant ( P<0.01 ) compared to those before the treatment.Conclusion Ultrasonography can clearly show the formation of bone erosion and osteophyte on tendon insertion sites and joints, and indentify abnormities such as tendon thickening, bursitis, synovial proliferation, and abnormal blood flow. Particularly, it can reflect bone change in AS patients in a real-time manner and monitor the treatment efficacy.